close menu

Lorenz Blog

Want to learn about new US Module 1 specifications? – Visit LORENZlink 2016 in April!

Posted on February 25, 2016

With the release of version 3.3 of its eCTD Module 1 specifications, the US FDA has enabled industry to streamline eSubmission processes. With these new features come added complexity that must be mastered to take full advantage of upgraded functionality. Join us at the inaugural LORENZlink RIM conference on April 4 – 5, 2016 in Scottsdale, AZ, for a detailed discussion of changes and lessons learned to ensure a successful transition to the new Module 1. You will learn about:

  • FDA experience with the new Module 1 including common validation errors
  • Considerations and best practices for transition
  • When and why grouped submissions make sense
  • Tips for preparing and submitting Promotional Labeling and Advertising in eCTD format
  • Updates on US FDA's upcoming eCTD mandate
Hopefully FDA will follow this update by senior leadership by pushing for an alignment in electronic submission programs across all centers. There are advancements in regulatory publishing coming soon (RPS) that can help industry reduce costs if FDA centers can agree to accept the same standards for regulatory review.

LORENZlink 2016, the first annual North American RIM conference will also include:

  • Interoperability challenges and solutions in the dawn of new requirements
  • Health Agency perspectives from Health Canada, FDA and more
  • Tracking data, and controlled vocabulary efficiency implications
  • Regulatory operational efficiency and KPIs
  • Content management and submission publishing by integrating in the cloud
  • Tutorial sessions with groups of 10 people on a variety of hot industry topics
  • docuBridge training for new features in 5.6, 5.7 and a preview of 5.8
For more information and to register for LORENZlink on April 4 – 5, 2016 in Scottsdale, AZ, click here!

This entry was posted in LORENZ Events.

To stay updated with the latest blog posts and news, follow us on:

© Copyright LORENZ Life Sciences Group. All rights reserved.